Does Humana Cover Weight Loss Treatment in Florida? A 2026 Guide

Last updated: September 2, 2026

Humana plans in Florida, which primarily consist of Medicare Advantage HMO, PPO, and D-SNP products alongside select commercial specialty offerings, may cover medically necessary obesity evaluations, lifestyle counseling, and certain weight management therapies when you see an in-network healthcare professional. Coverage is never automatic. Following Humana’s departure from the individual commercial major medical insurance market, most Florida beneficiaries holding Humana coverage fall under Medicare Advantage rules governed by CMS 42 CFR Part 422 rather than state commercial mandates. Always verify your specific plan benefits, deductible status, copayments, and drug formulary criteria before you schedule an appointment.

See if you may qualify for online weight loss treatment through Klarity’s network of 2,000+ licensed providers. You can also browse all medical conditions we treat.

TLDR

• Humana coverage in Florida centers predominantly on Medicare Advantage plans (including HMO, PPO, and Dual-Eligible Special Needs Plans, or D-SNPs). Standard individual and family Affordable Care Act (ACA) commercial plans are no longer offered by Humana in Florida.
• The Medicare GLP-1 Bridge program launched by the Centers for Medicare & Medicaid Services (CMS) on July 1, 2026 provides eligible Medicare Part D and Medicare Advantage beneficiaries with structured access to selected GLP-1 medications (including Wegovy, Zepbound, and Foundayo) at a fixed $50 monthly copayment. This federal demonstration operates outside standard Humana Pharmacy Solutions (HPS) Part D formularies, which historically excluded anti-obesity medications by statute.
• Federal Medicare Advantage statutory standards under CMS 42 CFR Part 422 establish that Medicare Advantage plans must provide benefits equal to or exceeding original Medicare Part B medical coverage for obesity screenings and behavioral interventions. State commercial insurance statutes such as Fla. Stat. § 627.668 (Florida’s mental health make-available statute) do not govern federal Medicare Advantage programs and do not mandate weight loss drug coverage.
• Florida Statutes § 456.47 governs the standard of care for telehealth practice across Florida, confirming virtual care as a recognized modality, but it does not mandate private or federal reimbursement parity or compel every insurer to pay for virtual visits.
• Pharmacy benefits on Humana plans generally process through Humana Pharmacy Solutions (HPS). Traditional Part D benefit packages exclude medications prescribed exclusively for weight loss unless authorized through clinical exceptions, secondary commercial employer riders, or federal demonstrations such as the Medicare GLP-1 Bridge.
• Phentermine and Qsymia are classified as Schedule IV controlled substances. Other weight management medications such as GLP-1 receptor agonists (Wegovy, Zepbound, Saxenda), Contrave, and orlistat are unscheduled. HHS and DEA telemedicine flexibilities governing controlled substance prescriptions currently remain effective through December 31, 2026.
• Cigna Prior Authorization Policy IP0477 (effective May 15, 2026) is an Express Scripts policy requiring PA on central nervous system stimulants; it does not apply to Humana weight management benefits.
• CVS/Caremark’s commercial formulary adjustments (such as Zepbound’s removal on July 1, 2025 and planned reinstatement on October 1, 2026) reflect Aetna and commercial employer decisions, not Humana’s Medicare Advantage Part D formulary rules.
• Verify your coverage directly using MyHumana or the customer service number printed on your insurance card. For Medicare Advantage coverage appeals or adverse determinations, beneficiaries follow the federal CMS appeals framework, escalating to Maximus Federal Services (the Medicare Independent Review Entity) at 1-855-887-6668. Dual-eligible members are also subject to Florida Agency for Health Care Administration (AHCA) Medicaid regulations. If you or someone you know is facing an acute emotional or psychiatric crisis, call or text 988.

Disclaimer: This article is published solely for educational and informational purposes. It does not constitute a formal coverage determination, medical diagnosis, or guarantee of financial reimbursement. Health insurance coverage, copayments, and prior authorization rules vary substantially across individual plan contracts. Always confirm your clinical eligibility and telehealth benefits directly with Humana before scheduling care.

Does Humana cover weight loss treatment in Florida?

In many cases, partial coverage may be available depending on your exact plan type, clinical diagnosis, and whether your clinician participates in Humana’s provider network. Outpatient clinical consultations, diagnostic blood work, and physician-supervised nutritional counseling often qualify as covered medical benefits under Humana Medicare Advantage plans when deemed medically necessary. However, coverage for anti-obesity prescription medications is subject to strict statutory boundaries and specialized program rules.

Because Humana phased out its commercial individual and family major medical health plans across Florida, the vast majority of Humana members in the state are enrolled in Medicare Advantage plans (Part C), standalone Medicare Part D prescription drug plans, or employer-sponsored group retiree policies. Under traditional Medicare Part D rules, medications labeled by the FDA solely for weight loss or weight management have historically been excluded from mandatory formulary inclusion. However, significant federal updates in 2026 provide new pathways for Florida seniors and eligible adults.

Do not confuse Humana’s coverage rules with those of Florida Blue (Blue Cross and Blue Shield of Florida), Anthem, Aetna, or Cigna. Each insurer utilizes distinct pharmacy benefit managers and commercial guidelines. To compare regional coverage, explore our companion Florida guides: Humana Florida ADHD guide, Humana Florida anxiety guide, Humana Florida depression guide, Aetna Florida weight loss guide, and Cigna Florida weight loss guide.

Check if your plan may cover a medical weight loss evaluation.

The 2026 Medicare GLP-1 Bridge program: what Florida Humana members must know

For Medicare beneficiaries enrolled in Humana Medicare Advantage plans in Florida, the most notable coverage development in 2026 is the Medicare GLP-1 Bridge program. Established by the Centers for Medicare & Medicaid Services (CMS), this initiative took effect on July 1, 2026 as a targeted demonstration designed to expand access to evidence-based obesity pharmacotherapies.

Historically, Section 1860D-2(e)(2)(A) of the Social Security Act prohibited Medicare Part D plans from covering drugs prescribed specifically for weight loss or anorexia. The Medicare GLP-1 Bridge creates a temporary federal framework bridging into broader value-based models, allowing eligible beneficiaries to obtain selected FDA-approved anti-obesity medications, such as Wegovy, Zepbound, and Foundayo, for a predictable out-of-pocket cost of $50 per month.

Important characteristics of the Medicare GLP-1 Bridge for Florida Humana members include:

• Program operation outside standard Part D formularies: The $50 monthly copayment is subsidized under the CMS demonstration structure rather than standard Humana Pharmacy Solutions tier schedules.
• Clinical qualifying criteria: Enrollees must meet established clinical benchmarks, typically including a body mass index (BMI) of 30 kg/m² or greater, or a BMI of 27 kg/m² or greater accompanied by at least one weight-related comorbidity (such as hypertension, dyslipidemia, or cardiovascular disease).
• Prescriber enrollment: The ordering healthcare professional must participate in authorized Medicare electronic prescribing and clinical tracking protocols.
• Commercial exclusion: This bridge program is exclusively a federal Medicare initiative. It does not apply to commercial employer plans, private marketplace policies, or uninsured individuals.

How prevalent is adult obesity in the United States?

Obesity is a complex, chronic metabolic health condition affecting tens of millions of American adults. Epidemiological data published by the Centers for Disease Control and Prevention in NCHS Data Brief No. 508, analyzing National Health and Nutrition Examination Survey (NHANES) findings from August 2021 through August 2023, documents the following national metrics:

• The overall age-adjusted prevalence of obesity among adults aged 20 and older was 40.3%, showing no statistically significant variation between men and women.
• The prevalence of severe obesity (defined as a BMI of 40 kg/m² or higher) stood at 9.4% across the adult population.
• Severe obesity rates were notably higher among adult women than men across every surveyed age bracket.
• Long-term surveillance from 2013–2014 through August 2021–August 2023 indicated that while general adult obesity remained relatively stable at elevated levels, severe obesity prevalence climbed from 7.7% to 9.7%.

While these federal epidemiological statistics underscore the widespread clinical need for chronic metabolic care, they do not dictate whether an individual Humana insurance policy will reimburse a specific clinical visit or medication.

Florida statutory rules and federal preemption: what applies to Humana?

Navigating health insurance regulations in Florida requires understanding which statutes apply to state-regulated commercial plans versus federally regulated Medicare products:

1. Federal Medicare Advantage Preemption (CMS 42 CFR Part 422): Under federal law, the standards established under Title XVIII of the Social Security Act and CMS 42 CFR Part 422 preempt state laws and regulations regarding Medicare Advantage benefit designs, marketing, and coverage determinations. As a result, Florida state insurance mandates do not dictate benefit structures for Humana Medicare Advantage members.
2. Fla. Stat. § 627.668: This Florida statute requires commercial group health insurers to make available benefits for the treatment of mental and nervous disorders. While frequently cited in behavioral healthcare, § 627.668 does not apply to obesity or weight loss treatments, nor does it override federal Medicare regulations.
3. Florida Telehealth Statute (Fla. Stat. § 456.47): Florida law defines telehealth as the use of synchronous and asynchronous telecommunications technology by a licensed health care practitioner to provide patient care, establish a valid practitioner-patient relationship, and issue prescriptions. While § 456.47 authorizes licensed Florida clinicians to deliver medical evaluations remotely, it does not mandate that commercial or Medicare Advantage payers reimburse virtual consultations at identical rates to in-person services. Coverage is determined by plan terms.
4. Federal Mental Health Parity and Addiction Equity Act (MHPAEA): MHPAEA ensures that financial requirements and treatment limitations on mental health benefits are no more restrictive than those applied to medical and surgical benefits. Because weight management pharmacotherapy is classified as a medical/metabolic service rather than a mental health benefit, MHPAEA does not compel coverage of anti-obesity drugs.

Humana Pharmacy Solutions (HPS) formulary tiers and weight loss medications

Prescription drug coverage for Humana enrollees is administered by Humana Pharmacy Solutions (HPS). Understanding how various categories of weight loss medications are handled helps avoid unexpected out-of-pocket pharmacy expenses:

Regulatory distinctions: clearing up common formulary confusion

Patients evaluating weight loss coverage frequently encounter conflicting news reports regarding drug formularies and clinical policies. It is essential to distinguish Humana’s specific guidelines from those of competing payers:

• CVS/Caremark Zepbound Timeline: Extensive media attention followed CVS/Caremark’s decision to remove Zepbound from its commercial standard preferred template lists effective July 1, 2025, with reinstatement scheduled for October 1, 2026. This timeline applies to commercial plans utilizing Caremark (such as Aetna and select corporate accounts). It does not govern Humana Medicare Advantage members, whose pharmacy benefits process through Humana Pharmacy Solutions.
• Cigna Prior Authorization Policy IP0477: Effective May 15, 2026, Cigna and Express Scripts implemented clinical policy IP0477, establishing stringent prior authorization criteria for central nervous system stimulants used in ADHD and narcolepsy. This is an Express Scripts commercial ADHD policy that has no bearing on Humana weight management coverage or GLP-1 authorizations.
• Express Scripts Zepbound Handling: Unlike CVS/Caremark, Express Scripts generally retained Zepbound on Tier 3 or Tier 4 on many commercial formularies. That policy is specific to Cigna and ESI clients and cannot be used to predict coverage on Humana plans.

Prescribing controlled substances vs. unscheduled medications via telehealth

Clinical management of weight loss may involve either unscheduled medications or DEA-controlled substances, each subject to distinct prescribing rules:

• Unscheduled Medications: GLP-1 receptor agonists (such as Wegovy, Zepbound, and Saxenda), Contrave, and orlistat are not controlled substances. Licensed healthcare practitioners in Florida may prescribe and refill these medications following a comprehensive virtual clinical evaluation conducted in compliance with Fla. Stat. § 456.47.
• Schedule IV Controlled Substances: Medications such as phentermine and Qsymia contain controlled substances. Under federal Ryan Haight Act guidelines, healthcare providers are generally required to conduct an in-person medical examination before issuing prescriptions for controlled substances. However, temporary federal telemedicine flexibilities enacted jointly by the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) permit qualified clinicians to prescribe Schedule II–V medications via synchronous video visits without an initial in-person exam through December 31, 2026. Florida clinicians must also query Florida’s prescription drug monitoring program (E-FORCSE) prior to prescribing.

Step-by-step: how Florida patients can verify Humana coverage and appeal denials

To avoid unexpected expenses and determine whether your weight management care is eligible for reimbursement, follow these practical steps:

1. Review Your Evidence of Coverage (EOC): Log into your MyHumana portal or consult your annual EOC booklet. Review the medical benefits section under “Nutritional Counseling” and “Weight Management Programs,” as well as the Chapter 6 prescription drug exclusions.
2. Check the HPS Drug Guide: Use Humana’s online Drug List search tool to check the formulary tier, quantity limits, and prior authorization requirements for medications like Wegovy, Zepbound, or phentermine.
3. Inquire About the Medicare GLP-1 Bridge: If you are enrolled in a Humana Medicare Advantage or Part D plan, contact customer service at the toll-free number on your member ID card. Ask specifically whether your plan participates in the federal Medicare GLP-1 Bridge demonstration and what clinical documentation your clinician must submit to access the $50 monthly copayment.
4. Verify In-Network Provider Status: Confirm that your treating physician or telehealth practice participates in Humana’s network for your specific plan network (HMO, PPO, or POS). Klarity provides patients with detailed itemized receipts (superbills) that can be submitted directly to insurers for potential out-of-network reimbursement when in-network coverage is not available.
5. Navigating Appeals and Disputes: If a prior authorization request or claim is denied, you have statutory appeal rights:
   • Medicare Advantage Appeals: File an organization determination redetermination with Humana within 60 days. If Humana upholds the denial, your file is automatically transmitted to Maximus Federal Services, the independent review entity (IRE) contracted by CMS, reachable at 1-855-887-6668.
   • Commercial Plan Appeals: Commercial policyholders who exhaust internal plan appeals may contact the Florida Department of Financial Services (DFS) Division of Consumer Services or the Florida Office of Insurance Regulation (FLOIR) at 1-877-693-5236 (1-877-MY-FL-CFO).
   • Medicaid / Dual-Eligible Appeals: Members covered under Humana Healthy Horizons or D-SNP plans are subject to oversight by the Florida Agency for Health Care Administration (AHCA) and Florida Medicaid Fair Hearing guidelines.

If you are experiencing severe emotional distress, suicidal ideation, or an acute behavioral health crisis, help is available immediately. Call or text the 988 Suicide & Crisis Lifeline anytime to reach confidential, free support.

Connect with a licensed provider through Klarity Health

Managing your metabolic health requires professional clinical oversight, personalized treatment plans, and continuous support. Klarity connects Florida patients with over 2,000 licensed, board-certified healthcare professionals experienced in comprehensive weight management, lifestyle optimization, and medication management.

Get started today by scheduling a weight loss consultation to review your medical history and explore evidence-based treatment options tailored to your needs.